Purehealth, headquartered in the United Arab Emirates (AE), is a leading player in the healthcare industry, specialising in innovative health solutions and services. Founded in 2015, the company has rapidly expanded its operations across the Middle East, establishing a strong presence in the region. With a focus on digital health, laboratory services, and wellness programmes, Purehealth is committed to enhancing patient care through advanced technology and personalised services. Their unique approach integrates cutting-edge diagnostics with comprehensive health management, setting them apart in a competitive market. Recognised for their contributions to healthcare, Purehealth has achieved significant milestones, including partnerships with various healthcare providers and institutions. Their dedication to improving health outcomes positions them as a trusted leader in the industry, continually striving to redefine the standards of healthcare in the region.
How does Purehealth's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Purehealth's score of 44 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Purehealth, headquartered in the United Arab Emirates (AE), reported total carbon emissions of approximately 593,827,000 kg CO2e. This figure includes 81,895,740 kg CO2e from Scope 1 emissions, 214,862,220 kg CO2e from Scope 2 emissions, and 10,000,948 kg CO2e from Scope 3 emissions, which encompasses waste generated in operations and end-of-life treatment of sold products. Purehealth has set ambitious climate commitments, aiming for a 90% reduction in absolute Scope 1, 2, and 3 greenhouse gas emissions by 2040, using 2022 as the baseline year. Additionally, the company has established near-term targets to reduce Scope 1 and 2 emissions by 42% by 2030. For Scope 3 emissions, a 25% reduction is targeted by the same year. Furthermore, Purehealth plans to transition to 100% renewable electricity sourcing by 2027, up from 0% in 2022. These commitments align with the Science Based Targets initiative (SBTi) and reflect Purehealth's dedication to achieving net-zero emissions across its value chain by 2040. The company's targets are classified as consistent with the reductions necessary to limit global warming to 1.5°C.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 533,000,000 | 000,000 | 00,000,000 | 
| Scope 2 | - | 000,000 | 000,000,000 | 
| Scope 3 | - | - | - | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Purehealth has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
